In the latest session, Biohaven Ltd (NYSE: BHVN) closed at $47.66 up 3.20% from its previous closing price of $46.18. In other words, the price has increased by $+1.48 from its previous closing price. On the day, 1065475 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Biohaven Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.99 and its Current Ratio is at 4.99. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on February 16, 2024, initiated with a Outperform rating and assigned the stock a target price of $62.
On February 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $59.
On December 22, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $50.H.C. Wainwright initiated its Buy rating on December 22, 2023, with a $50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 29 when Antonijevic Irina sold 11,000 shares for $41.79 per share. The transaction valued at 459,662 led to the insider holds 2,535 shares of the business.
CHILDS JOHN W bought 454,545 shares of BHVN for $9,999,990 on Oct 05. The Director now owns 3,998,952 shares after completing the transaction at $22.00 per share. On Oct 05, another insider, Coric Vlad, who serves as the Chief Executive Officer of the company, bought 340,908 shares for $22.00 each. As a result, the insider paid 7,499,976 and bolstered with 833,120 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 3.82B and an Enterprise Value of 3.61B.
Stock Price History:
Over the past 52 weeks, BHVN has reached a high of $50.68, while it has fallen to a 52-week low of $12.35. The 50-Day Moving Average of the stock is 44.45, while the 200-Day Moving Average is calculated to be 28.63.
Shares Statistics:
For the past three months, BHVN has traded an average of 1.07M shares per day and 847.31k over the past ten days. A total of 68.19M shares are outstanding, with a floating share count of 58.51M. Insiders hold about 14.41% of the company’s shares, while institutions hold 106.02% stake in the company. Shares short for BHVN as of Jan 31, 2024 were 6.69M with a Short Ratio of 6.25, compared to 7.48M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 8.34% and a Short% of Float of 9.52%.
Earnings Estimates
There are 11 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$1.41 for the current quarter, with a high estimate of -$1.14 and a low estimate of -$1.62, while EPS last year was -$3.32. The consensus estimate for the next quarter is -$1.39, with high estimates of -$1.18 and low estimates of -$1.59.
Analysts are recommending an EPS of between -$4.98 and -$5.5 for the fiscal current year, implying an average EPS of -$5.22. EPS for the following year is -$5.51, with 11 analysts recommending between -$4.06 and -$6.75.
